Published in Drug Week, April 27th, 2007
The study, involving asthma sufferers who have EIA, found that participants who had taken 1,500 mg of ascorbic acid for two weeks showed improved post-exercise lung function and a decreased concentration of biomarkers in their urine related to airway inflammation. This included the infamous leukotrienes, which play a key role in the inflammation that can lead to EIA.
The findings, appearing in the online issue of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.